NASDAQ:NVIV
Delisted
InVivo Therapeutics Holdings Corp. Stock News
$0.321
+0 (+0%)
At Close: May 10, 2024
Best Penny Stocks To Watch For July 2021
01:39pm, Wednesday, 14'th Jul 2021
Penny Stocks For Your Watch List In July The post Best Penny Stocks To Watch For July 2021 appeared first on Penny Stocks to Buy, Picks, News and Information | PennyStocks.com.
NVIV Stock Increases Over 36% Intraday: Why It Happened
03:43pm, Tuesday, 13'th Jul 2021
The stock price of Invivo Therapeutics Holdings Corp (NASDAQ: NVIV) increased by over 36% during intraday trading. This is why it happened.
InVivo Therapeutics Stock Moves Higher On FDA Acceptance Of Preclinical Module For Neuro-Spinal Implant
09:13am, Tuesday, 13'th Jul 2021
The FDA has accepted InVivo Therapeutics Holdings Corp's (NASDAQ: NVIV) preclinical module, which is one of three individual modules required for the Company's humanitarian device exemption (HDE) a
InVivo Therapeutics Urges All Stockholders to Vote at the 2021 Annual Meeting to Be Held on Friday July 16, 2021
08:05am, Tuesday, 06'th Jul 2021
CAMBRIDGE, Mass.--(BUSINESS WIRE)--InVivo Therapeutics Holdings Corp. (Nasdaq: NVIV), a research and clinical-stage biomaterials and biotechnology company with a focus on the treatment of spinal cord
CAMBRIDGE, Mass.--(BUSINESS WIRE)--InVivo Therapeutics Holdings Corp. (Nasdaq: NVIV), a research and clinical-stage biomaterials and biotechnology company with a focus on the treatment of spinal cord
InVivo Therapeutics Announces Presentation at Upcoming 2021 H.C. Wainwright Global Life Sciences Conference
08:00am, Friday, 05'th Mar 2021
CAMBRIDGE, Mass.--(BUSINESS WIRE)--InVivo Therapeutics Holdings Corp. (Nasdaq: NVIV), a research and clinical-stage biomaterials and biotechnology company with a focus on the treatment of spinal cord
InVivo Therapeutics Announces Publication in Peer-Reviewed Journal of Neurosurgery: Spine
08:00am, Tuesday, 16'th Feb 2021
CAMBRIDGE, Mass.--(BUSINESS WIRE)--InVivo Therapeutics Holdings Corp. (Nasdaq: NVIV) today announced the recent publication of a peer-reviewed manuscript in the Journal of Neurosurgery: Spine describi
SCI Adds Merchants Fleet to Growing Customer Offerings
03:18pm, Monday, 19'th Oct 2020
SCI has launched a national fleet rental and leasing program for its Logistics Brokers that will enable business growth by reducing vehicle costs.
NYC teacher suspected of sexual relationship with student invokes Fifth Amendment
01:35am, Sunday, 18'th Oct 2020
David Lado invoked the Fifth Amendment against self-incrimination when asked by city school investigators about his relationship with a female student, records show.
12 Healthcare Stocks Moving In Friday's After-Market Session
12:00am, Friday, 16'th Oct 2020
Gainers
InVivo Therapeutics Hldg (NASDAQ:NVIV) shares rose 11.11% to $1.5 during Friday's after-market session. InVivo Therapeutics Hldg's trading volume hit 1.4K shares...
ClearPoint Neuro: Becoming The World's Pre-Eminent Neurosurgery Platform (NASDAQ:CLPT)
01:30pm, Wednesday, 14'th Oct 2020
20 Gene Therapy Clinical Trials Using the ClearPoint platform. Utilizes Razor / Blades Business Model.
Analysts Expect ClearPoint Neuro, Inc. (NASDAQ:CLPT) Will Announce Earnings of -$0.14 Per Share
07:36am, Tuesday, 13'th Oct 2020
Equities analysts expect ClearPoint Neuro, Inc. (NASDAQ:CLPT) to post earnings per share (EPS) of ($0.14) for the current quarter, according to Zacks. Two analysts have provided estimates for ClearPoi
Découvrez le comportement inhabituel qu'ont eu les Français cet été face au Livret A. Si vous êtes redevable d'un solde d'impôt sur le revenu, sachez à quel moment il vous sera prélevé
Stryker Marks One Million Mesa Pedicle Screw Implantations Globally
12:00am, Monday, 05'th Oct 2020
Stryker marks one million Mesa Pedicle Screw Implantations globally, and will virtually showcase Mesa at the NASS annual meeting, Oct. 6-9.
Covid or Not, This Company Has No Repeat Customers
06:42pm, Tuesday, 29'th Sep 2020
Lots of industries have seen demand pulled forward by the Covid-19 pandemic, but a death-care company is trying to figure out when it would have seen that demand anyway.